SINGAPORE (April 26): OCBC Investment Research is downgrading Raffles Medical Group to “hold” because of the limited upside from its current share price, although it is sticking to its $4.72 fair value estimate.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $4.99/month*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply